Lisa Deschamps is the CEO of AviadoBio, a neuroscience biotech who has done this three times over. She in-licensed an ophthalmology asset from a Chinese company. She is now running two additional clinical development programs in China through IIT structures. And she did all of this after a first deal that collapsed a week before signing, with all the dysfunction and lack of transparency that feed the worst assumptions about doing business in China.

This session is open to our Premium (paid) members. 

Mihriban Tuna - CEO Immutrin
Tom Goodman - Cooley LLP

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Tim Knotnerus - CEO of Agomab
MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

As leaders, most of you are currently in a transition moment. Markets are opening up after a difficult few years and most of you are having to shift from survival mode into growth mode.

The risk is that the thinking that got you through the downturn is the same thinking that will slow you down now.

Jennifer joined our community a year ago and her session was nothing short of brilliant. We are grateful to have her back.

This session is open to our Premium (paid) members. 

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

We look forward to welcoming our members to a CEO dinner at Bio€quity.

When a chair comes on board many things are assumed and therein often lies the problem. Your chair is (hopefully) the one person on your board without a fund to answer to – are you maximising that relationship?

This session is open to our Premium (paid) members. 

Christine has over 20 years in the life-science industry including business development, corporate strategy, and venture investment. She is currently a Partner at Johnson & Johnson’s corporate development group, JJDC. At JJDC is a board director at PAQ Therapeutics.

This session is open to our Premium (paid) members. 

This session is a masterclass in design and strategic communication. It is an opportunity to see how seemingly subtle design decisions can materially influence how your story is understood, remembered, and valued.

This session is open to our Premium (paid) members. 

In this session, Peter Wong and Alex Saunders, co-founders of Flywheel, will walk through a systems-based approach to CEO-led content on LinkedIn, built for leaders who do not have hours to spare.

This session is open to our Premium (paid) members. 

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

When you are trying to sign a deal in Asia (and particularly China) the rules, explicit and implicit, are not always our own. The assumption that contractual clarity guarantees alignment is a Western bias. In high-context cultures, negotiation is less about price or term sheets and more about trust, hierarchy, and the preservation of harmony.

This session is open to our Premium (paid) members. 

In science-led organizations, the executive burden to move quickly and deliver outcomes often leads us to default to providing answers. Yet as Harvard Business Review observes, “the role of the manager, in short, is becoming that of a coach” (HBR, The Leader as Coach). Coaching is no longer peripheral—it is increasingly seen as a leadership behaviour that improves both execution and culture when practiced consistently.

This session is open to our Premium (paid) members. 

Many of you are now operating under pressure that no longer peaks and dips, it simply persists. Fundraising rounds drag on, board dynamics are increasingly difficult, teams are strained; and in most cases, the mission you’re driving is one that touches you personally. 

This session is open to our Premium (paid) members. 

Craig Marshall - CEO of OrganOx
MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Better boards start with better conversations

By invitation only.

Jim Geraghty - Chair OMass Therapeutics
CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

John Glasspool - CEO of VarmX
MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Miquel Vila-Perelló - co-founder and CEO of SpliceBio
MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Chris Sheldon - Senior Vice President, Global Head Business Development GSK
CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

Too many CEOs enter boardrooms with a collaborative, consensus-seeking approach that works in some contexts but can backfire when facing investor boards. The tendency to defer, seek permission, or accommodate every concern signals uncertainty to investors who need to see strength.

This session is open to our Premium (paid) members. 

Budget cuts and layoffs don’t just affect business operations; they also hit people emotionally. Most CEOs have already processed the decision by the time the team hears it. That creates an emotional gap. If you’re not aware of it and don’t adjust for it, you’ll seem out of touch. That’s when trust breaks.

This session is open to our Premium (paid) members. 

Emanuele Ostuni - founding CEO of ArtBio GmbH
MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

How do we lead when we’re emotionally exhausted, uncertain of the next viable step, and conscious that the bold vision we once sold—internally and externally—is now under revision?

This session is open to our Premium (paid) members. 

Jean-Christophe Tellier - Chief Executive Officer at UCB
CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members.